NCT06380543

Brief Summary

Papillary cannulation attempts have been shown to be an independent predictor of post-ERCP pancreatitis (PEP) when they are repeated more than 5 times or for 5 minutes or when the pancreatic duct is opacified or cannulated by using guidewire more than 1 time. In order to reduce complications, the 2016 ESGE guideline recommends a precise sequence of alternative cannulation techniques to the primary guidewire approach before exceeding the stated limits. However, there are no published data about the routinary application of this biliary cannulation algorithm. The investigators hypothesised that the ESGE algorithm predicts an increased cannulation success. Nevertheless, it's unclear if this benefit is also associated with a decreased risk of complications, mainly post-procedural pancreatitis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Dec 2019

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 12, 2019

Completed
4.4 years until next milestone

First Submitted

Initial submission to the registry

April 18, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 24, 2024

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 30, 2025

Completed
Last Updated

May 13, 2025

Status Verified

May 1, 2025

Enrollment Period

5.1 years

First QC Date

April 18, 2024

Last Update Submit

May 7, 2025

Conditions

Keywords

ERCPbiliary cannulationpost-ERCP complications

Outcome Measures

Primary Outcomes (1)

  • Success of ERCP biliary cannulation rate

    Success obtained with the different cannulation techniques according with the ESGE algorithm

    At the end of the procedure.

Secondary Outcomes (1)

  • ERCP complication rates

    At 0-72 hours, and at 30-days after the procedure.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with either benign or primary/secondary malignant bile duct disease.

You may qualify if:

  • patients \> 18 years of age;
  • native papilla;
  • signed Informed Consent;

You may not qualify if:

  • previous biliary sphincterotomy;
  • post-surgical ERCP;
  • ampulloma or papilla involved by a tumor;
  • pancreatic endotherapy;
  • patients unable to give consent for the procedure;

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

IRCCS OSpedale San Raffaele

Milan, Italy, 20132, Italy

Location

MeSH Terms

Conditions

Biliary Tract Diseases

Condition Hierarchy (Ancestors)

Digestive System Diseases

Study Officials

  • Alberto Mariani, MD

    IRCCS Ospedale San Raffaele

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 18, 2024

First Posted

April 24, 2024

Study Start

December 12, 2019

Primary Completion

December 31, 2024

Study Completion

March 30, 2025

Last Updated

May 13, 2025

Record last verified: 2025-05

Locations